The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II StudyWenqun Xing, Quanli Gao, Baozhen Ma et al.|Frontiers in Immunology|2021Cited by 73
The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.Lingdi Zhao, Quanli Gao, Wenqun Xing et al.|Journal of Clinical Oncology|2021Cited by 15
Toripalimab Used on the Same Day or Third Day With Chemotherapy for Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II StudyWenqun Xing, Quanli Gao, Lingdi Zhao et al.|Research Square|2021Cited by 0